Tirzepatide (Zepbound) received FDA approval in December 2024 for moderate-to-severe obstructive sleep apnea in adults with obesity, based on the SURMOUNT-OSA trials published in the New England Journal of Medicine (Malhotra et al., 2024)
Here enters the Gila monster, the largest lizard in North America
A common change that has a lot of people worried is how plans are handling GLP-1 medications diabetes and weight loss drugs you may know better by their common brand names, like Ozempic, Wegovy, Mounjaro, and Zepbound
Not the best fit for the titration phase, you wont be able to use it all before it degrades
View Product What Are Retatrutide and Survodutide
Retatrutide (not yet approved) - Find Medical Weight Loss Doctors in Amsterdam, New York We accept hundreds of insurance plans And many more